-
LGND Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ligand Pharmaceuticals (LGND)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 72.31 mm | 72.31 mm | 72.31 mm | 72.31 mm | 72.31 mm | 72.31 mm |
Cash burn (monthly) | (no burn) | (no burn) | 13.07 mm | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 27.18 mm | n/a | n/a | n/a |
Cash remaining | n/a | n/a | 45.13 mm | n/a | n/a | n/a |
Runway (months of cash) | n/a | n/a | 3.5 | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 250 |
Opened positions | 40 |
Closed positions | 29 |
Increased positions | 105 |
Reduced positions | 59 |
13F shares | Current |
---|---|
Total value | 1.86 tn |
Total shares | 18.16 mm |
Total puts | 5.20 k |
Total calls | 30.80 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 2.95 mm | $315.67 bn |
Vanguard | 2.09 mm | $223.47 bn |
JHG Janus Henderson | 1.02 mm | $108.76 bn |
MQBKY Macquarie Group Limited | 884.38 k | $94.76 bn |
STT State Street | 743.63 k | $79.68 bn |
Dimensional Fund Advisors | 723.02 k | $77.47 bn |
Congress Asset Management | 621.48 k | $66.59 bn |
Stephens Investment Management | 612.78 k | $65.66 bn |
Chicago Capital | 551.59 k | $59.10 bn |
Geode Capital Management | 438.44 k | $46.99 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 25 | Andrew Reardon | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 876 | 105.12 k | 28,368 |
15 Feb 25 | Andrew Reardon | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 1,114 | 133.68 k | 29,244 |
15 Feb 25 | Octavio Espinoza | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 1,221 | 146.52 k | 23,879 |
15 Feb 25 | Octavio Espinoza | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 782 | 93.84 k | 25,100 |
15 Feb 25 | Octavio Espinoza | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 1,024 | 122.88 k | 25,882 |
15 Feb 25 | Davis Todd C | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 4,255 | 510.60 k | 130,342 |
15 Feb 25 | Davis Todd C | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 2,231 | 267.72 k | 134,597 |
14 Feb 25 | Andrew Reardon | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 1,758 | 210.96 k | 30,358 |
14 Feb 25 | Andrew Reardon | Common Stock | Grant | Acquire A | No | No | 0 | 5,429 | 0.00 | 32,116 |
14 Feb 25 | Andrew Reardon | Common Stock | Payment of exercise | Dispose F | No | No | 120 | 2,775 | 333.00 k | 26,687 |